Save time and get answers to complex questions with AI chat
Patent expiration eu dabrafenib?Mebendazole for kids price?Brenzavvy discontinuation?When will tenofovir alafenide come off patent in canada?How to apply for vascepa's patient assistance?
See the DrugPatentWatch profile for Abciximab
Abciximab is sold under the trade name ReoPro. [1]
Based on the available information, ReoPro is the main trade name associated with abciximab. [1]
Abciximab is an antiplatelet medicine used to reduce the risk of ischemic complications in certain high-risk coronary procedures, such as during percutaneous coronary intervention (PCI). [1]
If you are searching for dosing, prescribing information, or safety details, using the trade name (ReoPro) helps ensure you match the exact marketed product that corresponds to the active ingredient abciximab. [1]
[1] https://www.drugs.com/monograph/abciximab.html
Other Questions About Abciximab :